Pathology of non-alcoholic fatty liver disease

被引:42
作者
Cataldo, Ivana [1 ]
Sarcognato, Samantha [1 ]
Sacchi, Diana [1 ]
Cacciatore, Matilde [1 ]
Baciorri, Francesca [1 ]
Mangia, Alessandra [2 ]
Cazzagon, Nora [3 ]
Guido, Maria [1 ,4 ]
机构
[1] Azienda ULSS 2 Marca Trevigiana, Dept Pathol, Piazzale Osped 1, Treviso, Italy
[2] Fdn IRCCS Casa Sollievo della Sofferenza, Dept Med Sci, Liver Unit, San Giovanni Rotondo, Italy
[3] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[4] Univ Padua, Dept Med DIMED, Padua, Italy
关键词
fatty liver; steatohepatitis; non-alcoholic; metabolic syndrome; SCORING SYSTEM; STEATOHEPATITIS; NAFLD; DIAGNOSIS; FIBROSIS; PROGRESSION; DEFINITION; PREVALENCE; ALGORITHM; BIOPSY;
D O I
10.32074/1591-951X-242
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of different conditions which are characterized by hepatic steatosis in the absence of secondary causes. It is currently the most common chronic liver disease worldwide, and its estimated prevalence is about 1.5-6.5%. The only histological finding of steatosis ("simple" steatosis) represents the uncomplicated form of NAFLD, while non-alcoholic steatohepatitis (NASH) is its inflammatory subtype associated with disease progression to cirrhosis and hepatocellular carcinoma (HCC), and represents the major indication for liver transplantation. NASH is still a diagnostic and therapeutic challenge for clinicians and liver biopsy is currently the only accepted method to reliably distinguish NASH from "simple" steatosis. From the histological perspectives, NAFLD and NASH continue to be an area of active interest for pathologists, with a specific focus on better methods of evaluation, morphologic clues to pathogenesis, and predictors of fibrosis progression. This review focuses on histopathology of NAFLD in adults, with the aim to provide a practical diagnostic approach useful in the clinical routine.
引用
收藏
页码:194 / 202
页数:9
相关论文
共 35 条
[1]   The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease [J].
Adams, LA ;
Lindor, KD ;
Angulo, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (07) :1316-1320
[2]   A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis [J].
Altamirano, Jose ;
Miquel, Rosa ;
Katoonizadeh, Aezam ;
Abraldes, Juan G. ;
Duarte-Rojo, Andres ;
Louvet, Alexandre ;
Augustin, Salvador ;
Mookerjee, Rajeshwar P. ;
Michelena, Javier ;
Smyrk, Thomas C. ;
Buob, David ;
Leteurtre, Emmanuelle ;
Rincon, Diego ;
Ruiz, Pablo ;
Garcia-Pagan, Juan Carlos ;
Guerrero-Marquez, Carmen ;
Jones, Patricia D. ;
Barritt, A. Sidney ;
Arroyo, Vicente ;
Bruguera, Miquel ;
Banares, Rafael ;
Gines, Pere ;
Caballeria, Juan ;
Roskams, Tania ;
Nevens, Frederik ;
Jalan, Rajiv ;
Mathurin, Philippe ;
Shah, Vijay H. ;
Bataller, Ramon .
GASTROENTEROLOGY, 2014, 146 (05) :1231-+
[3]   Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[4]   Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials [J].
Anstee, Quentin M. ;
Lawitz, Eric J. ;
Alkhouri, Naim ;
Wong, Vincent Wai-Sun ;
Romero-Gomez, Manuel ;
Okanoue, Takeshi ;
Trauner, Michael ;
Kersey, Kathryn ;
Li, Georgia ;
Han, Ling ;
Jia, Catherine ;
Wang, Lulu ;
Chen, Guang ;
Subramanian, G. Mani ;
Myers, Robert P. ;
Djedjos, C. Stephen ;
Kohli, Anita ;
Bzowej, Natalie ;
Younes, Ziad ;
Sarin, Shiv ;
Shiffman, Mitchell L. ;
Harrison, Stephen A. ;
Afdhal, Nezam H. ;
Goodman, Zachary ;
Younossi, Zobair M. .
HEPATOLOGY, 2019, 70 (05) :1521-1530
[5]   Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis [J].
Anstee, Quentin M. ;
Targher, Giovanni ;
Day, Christopher P. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (06) :330-344
[6]   Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential [J].
Bedossa, Pierre .
LIVER INTERNATIONAL, 2018, 38 :64-66
[7]   Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease [J].
Bedossa, Pierre .
HEPATOLOGY, 2014, 60 (02) :565-575
[8]   Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients [J].
Bedossa, Pierre ;
Poitou, Christine ;
Veyrie, Nicolas ;
Bouillot, Jean-Luc ;
Basdevant, Arnaud ;
Paradis, Valerie ;
Tordjman, Joan ;
Clement, Karine .
HEPATOLOGY, 2012, 56 (05) :1751-1759
[9]   NAFLD: Reporting Histologic Findings in Clinical Practice [J].
Brunt, Elizabeth M. ;
Kleiner, David E. ;
Carpenter, Danielle H. ;
Rinella, Mary ;
Harrison, Stephen A. ;
Loomba, Rohit ;
Younossi, Zobair ;
Neuschwander-Tetri, Brent A. ;
Sanyal, Arun J. .
HEPATOLOGY, 2021, 73 (05) :2028-2038
[10]   Portal Chronic Inflammation in Nonalcoholic Fatty Liver Disease (NAFLD): A Histologic Marker of Advanced NAFLD-Clinicopathologic Correlations from the Nonalcoholic Steatohepatitis Clinical Research Network [J].
Brunt, Elizabeth M. ;
Kleiner, David E. ;
Wilson, Laura A. ;
Unalp, Aynur ;
Behling, Cynthia E. ;
Lavine, Joel F. ;
Neuschwander-Tetri, Brent A. .
HEPATOLOGY, 2009, 49 (03) :809-820